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background: The relationship of serum lipid levels, aggressive statin use and progression of carotid stenosis (CS) severity has not been 
well studied. We assessed the correlation between aggressive risk modification, statin use, and lipid levels with progression of carotid 
artery stenosis and incidence of ischemic stroke (IS) / TIA.
Methods: We conducted a retro-prospective analysis of patients who had at least 2 serial carotid ultrasounds (CUS) between 2001 
and 2014. Asymptomatic patients with mild (<50%) and moderate (50% to 79%) CS were included. Outcomes assessed were: carotid 
revascularization, IS/TIA and progression of CS (PCSS). PCSS was defined as an increase in CS severity by a grade or the velocity (> 
20%). Baseline characteristics, use of medications and control of lipid profile were obtained at baseline and at follow-up CUS. 
Results:  A total of 3972 CUS (622 patients) with the mean follow-up duration of 65±33 months were included. Baseline CUS revealed 
mild CS in 67% and moderate CS in 33%patients. PCSS was seen in 11% of patients with annual incidence of 2%. Predictors of PCSS 
were high LDL, low dose or absence of statin use, current smoking, peripheral arterial disease (PAD), female sex, Hemoglobin A1C>7% 
and High BMI >30. The annual rate of IS/TIA or revascularization was 1.2%. IS/TIA and revascularization were associated with poorly 
controlled HTN, LDL>100mg/dl, chronic kidney disease, PAD and high degree of carotid stenosis on the first visit. On multivariate analysis 
LDL>100mg/dl, lower potency or absence of statin use and current smoking were independent risk factors for PCSS. Similarly multivariate 
analysis revealed LDL>100mg/dl, high degree of carotid stenosis on the first visit and PCSS as independent risk factors for IS/TIA and 
revascularization. In patients with LDL<70mg/dl, annual incidence of CVA, TIA or revascularization were 0.8%, compared to 3.8% in the 
patients with LDL>100mg/dl, (P=0.04) and PCSS was seen only in 4% of the patients with LDL<70mg/dl, as compared to 16% of the 
patients with LDL<100mg/dl (P=0.03). 
conclusion: This study demonstrates that more intense medical therapy, especially tighter LDL control results in lower risk of PCSS and 
IS/TIA.
